The β-site amyloid precursor protein-cleaving enzyme BACE1 is a prime medication target for Alzheimer disease. BACE1 cleavage sites in the membrane-proximal parts of L1 (between Tyr1086 and Glu1087) and CHL1 (between Gln1061 and Asp1062) had been dependant on mass spectrometry. This function provides molecular insights in to the function as well as the pathways where… Continue reading The β-site amyloid precursor protein-cleaving enzyme BACE1 is a prime medication